))
Ep. 13: Edward Lanphier, chief editing officer
Manage episode 337513031 series 3382327
Content provided by GuidePost and The CRISPR Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GuidePost and The CRISPR Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
The recently retired founding CEO of Sangamo Therapeutics, Edward Lanphier, shares stories from two decades at the helm of the first biotech company to develop and take genome editing, using zinc finger nucleases, into the clinic.
…
continue reading
20 episodes
Share
